Literature DB >> 15558954

Effects of some antibiotics on human erythrocyte 6-phosphogluconate dehydrogenase: an in vitro and in vivo study.

Mehmet Akyüz1, Mustafa Erat, Mehmet Ciftçi, Kenan Gümüştekin, Nuri Bakan.   

Abstract

The in vitro and in vivo effects of some antibiotics on human erythrocyte 6-phosphogluconate dehydrogenase were investigated. Human erythrocyte 6-phosphogluconate dehydrogenase was purified with ammonium sulphate precipitation, 2',5' ADP-Sepharose 4B affinity and gel filtration chromatography. Some antibiotics (netilmicin sulphate, cefepime, amikacin, isepamycin, chloramphenicol, ceftazidim, teicoplanin, ampicillin, ofloxacin, levofloxacin, cefotaxime, penicillin G, gentamicin sulphate, ciprofloxacin) inhibited enzyme activity in vitro but others (cefozin, decefin, streptomycin, combisid, and meronem) were devoid of inhibitory effects. For the drugs having low IC50 values (netilmicin sulphate and cefepime), in vivo studies were performed in rats. Netilmicin sulphate at 15-mg/kg inhibited enzyme activity significantly (p < 0.001) 1 h, 2 h, and 3 h after dosing and cefepime at 200-mg/kg very significantly (p < 0.001) inhibited the enzyme 1 h and 2 h after dosing. Netilmicin sulphate and cefepime inhibited rat erythrocyte 6-phosphogluconate dehydrogenase both in vivo and in-vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558954     DOI: 10.1080/14756360409162451

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  2 in total

1.  Biochemical and structural insights into 6-phosphogluconate dehydrogenase from Leishmania donovani.

Authors:  Pranay Jakkula; Bandigi Narsimulu; Insaf Ahmed Qureshi
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-12       Impact factor: 4.813

2.  Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning.

Authors:  Kate Wang; Eden L Romm; Valentina L Kouznetsova; Igor F Tsigelny
Journal:  Molecules       Date:  2020-08-26       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.